NEWS
- Discovery of kidney cancer driver could lead to new treatment strategy
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. University of North C
- Li Gang, Chairman of Sihuan Pharmaceutical Co., Ltd. , visits Bangladesh
Li Gang, the chairman of Sihuan Pharmaceutical Co., Ltd. went to Bangladesh to visit the Ministry of Health of Bangladesh (BDH) and the Bangladesh Pharmaceutical Federation (BAPI) and held talks with
- The listing application is approved by CFDA Boehringer Ingelheim blockbuster drug diethylsulfonate nid
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial lung disease. The lesions are confined to the lungs and are more common in the elderly.
- China rejects patent on hepatitis C drug sofosbuvir
The Chinese patent office has rejected a patent application for the blockbuster hepatitis C treatment sofosbuvir, increasing the possibility of a generic version of the drug to become available in Chi
- 2019 CPHI Exhibition in India
2019 CPHI Exhibition in India
- 2019 CHPI Exhibition in Shanghai
In the summer of 2019，we are came to shanghai again for 2019 Shanghai CPHI exhibition. The exhibition this year stated on June 18th, ended on June 20th. It always rains during exhibition like every ye